Incyte CEO on New Drugs, Jakafi Applications

Feb. 20 (Bloomberg) -- Herve Hoppenot, chief executive officer of Incyte Corp., talks with Bloomberg’s Meg Tirrell about the company's Jakfi drug used to treat a bone marrow disorder called myelofibrosis, Incyte's drug pipeline and the outlook for growth. Shares of the cancer-drug maker have tripled in the last year. (Source: Bloomberg)
Samsung S6 Is a Step in the Right Direction: Cain
11:46 - March 2 -- Asia Pacific Research CEO Geoffrey Cain discusses Samsung's unveiling of the S6 and S6 Edge, featuring a three-sided screen, with Bloomberg's Rishaad Salamat on "Trending Business."
  • Modi's Budget Isn't Game Changer Investors Wanted: Iley
  • Samsung S6 an Improvement, Not `Smash Hit': IDC's Ma
  • China Stocks Favored on Monetary Policy: Chandgothia